Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Medtronic
McKesson
Fish and Richardson
Julphar
Teva

Generated: June 26, 2019

DrugPatentWatch Database Preview

MYLAN PHARMS INC Company Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?

MYLAN PHARMS INC has one hundred and sixteen approved drugs.

There are twenty-nine tentative approvals on MYLAN PHARMS INC drugs.

Summary for MYLAN PHARMS INC
US Patents:0
Tradenames:103
Ingredients:101
NDAs:116

Drugs and US Patents for MYLAN PHARMS INC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc ESZOPICLONE eszopiclone TABLET;ORAL 091151-001 Mar 26, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc TRAZODONE HYDROCHLORIDE trazodone hydrochloride TABLET;ORAL 090514-001 Jun 2, 2009 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090521-001 May 31, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc LEVETIRACETAM levetiracetam TABLET, EXTENDED RELEASE;ORAL 200475-001 Dec 19, 2011 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Pharms Inc IRBESARTAN AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; irbesartan TABLET;ORAL 077969-001 Sep 27, 2012 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for MYLAN PHARMS INC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,444,769 ➤ Try a Free Trial
Mylan Pharms Inc AVITA tretinoin CREAM;TOPICAL 020404-003 Jan 14, 1997 4,971,800 ➤ Try a Free Trial
Mylan Pharms Inc MAXZIDE hydrochlorothiazide; triamterene TABLET;ORAL 019129-001 Oct 22, 1984 4,105,783 ➤ Try a Free Trial
Mylan Pharms Inc MAXZIDE-25 hydrochlorothiazide; triamterene TABLET;ORAL 019129-003 May 13, 1988 4,444,769 ➤ Try a Free Trial
Mylan Pharms Inc AVITA tretinoin CREAM;TOPICAL 020404-003 Jan 14, 1997 5,045,317 ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Johnson and Johnson
Deloitte
Fish and Richardson
Mallinckrodt
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.